MICHAEL NGUYEN: Open Payments
NPI 1356958557 · SAN FRANCISCO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$164 in 6 payments from 5 companies in 2025. Trend: 2023 $40 · 2024 $190 · 2025 $164
Food & beverage: $164
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 2 | $51 |
| ABBVIE INC. | 1 | $33 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Biogen, Inc. | 1 | $28 |
| Lundbeck LLC | 1 | $25 |
Products named: SPRAVATO, VRAYLAR, CAPLYTA, ZURZUVAE, REXULTI.
Industry payments across CA — which companies pay providers there.
